References

1. Lawrence RC, Helmick CG, Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 41(5): 778-799. PubMed | Google Scholar


2. Chakravarty EF, Bush TM, Manzi S et al. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007; 56(8): 2092-2094. PubMed | Google Scholar


3. Pons-Estel GJ, Alarcón GS, Scofield L et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin arthritis rheum. 2010; 39(4): 257-268. PubMed | Google Scholar


4. Uramoto KM, Michet CJ Jr, Thumboo J et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis rheum. 1999; 42(1): 46-50. PubMed | Google Scholar


5. Petri M. Epidemiology of systemic lupus erythematosus. Best pract res clin rheumatol. 2002; 16(5): 847-858. PubMed | Google Scholar


6. Tan EM, Cohen AS, Fries JF et al. The revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum. 1982 Nov; 25(11): 1271-7. PubMed | Google Scholar


7. Symmons DP. Frequency of lupus in people of African origin. Lupus. 1995; 4(3): 176-178. PubMed | Google Scholar


8. Kaballo BG, Wahab AA, Nur MM et al. Ethnic distribution and clinical features of systemic lupus erythematosus in the Sudan. Sudan Med J. 2009; 45(2): 49-57. PubMed | Google Scholar


9. Khalifa EH, Kaballo BG, Suleiman SM, Khalil EA, El-Hassan AM. Pattern of glomerulonephritis in Sudan: histological and immunofluorescence study. Saudi J Kidney Dis Transpl. 2004; 15(2): 176-179. PubMed | Google Scholar


10. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9): 1725. PubMed | Google Scholar


11. Petri M, Orbai AM, Alarcón GS et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8): 2677-2686. PubMed | Google Scholar


12. Hiepe F, Burmester GR. Klink und Diagnostik des systematischen Lupus erythemadodes. Hematology medical journal. 2006; 121: 1129-1133. Google Scholar


13. Harley JB, Gaither KK. Autoantibodies. Rheumatic Disease Clinicals of North America. 2009; 14: 43-56. Google Scholar


14. Hahn BH, Mcmahon MA, Wilkinson A et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis care & research. 2012; 64(6): 797-808. PubMed | Google Scholar


15. Markowitz GS, D'Agati VD. Classification of lupus nephritis. Current opinion in nephrology and hypertension. 2009; 18(3): 220-225. PubMed | Google Scholar


16. Ballou SP, Khan MA, Kushner L. Clinical features of SLE: differences related to race and age of onset. Arthritis Rheum. 1982; 25(1): 55-60. PubMed | Google Scholar


17. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus, identification of racial and socioeconomic influences. Arch Intern Med. 1990 Apr; 150(4): 849-53. PubMed | Google Scholar


18. Peakman M, Vergani D, Horne T, Laing A. Immune-mediated nephritis and vasculitis in: basic and clinical immunology. Edinburgh: Churchill Livingstone. 2009; 2: 230-231. Google Scholar


19. Cooper GS, Dooley MA, Treadwell EL et al. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998; 41(10): 1714-1724. PubMed | Google Scholar


20. Chapel H, Heaney M, Misbah S, Snowden N. Immunodeficiency in: essential of clinical immunology Inc, 350 Main Street, Malden, Massachusetts 02148-5020, USA. Blackwell Publishing. 2006; 5: 67. Google Scholar


21. McKinley PS, Ouellette SC, Winkel GH. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus, a proposed model. Arthritis Rheum. 1995; 38(6): 826-834. PubMed | Google Scholar


22. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993; 37(7): 753-762. PubMed | Google Scholar


23. Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology. 2000; 39: 1249-1254. PubMed | Google Scholar


24. Jump RL, Robinson ME, Armstrong AE et al. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005; 32(9): 1699-1705. PubMed | Google Scholar


25. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003; 82(5): 299-308. PubMed | Google Scholar


26. Greco CM, Rudy TE, Manzi S. Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory. Pain Med. 2003; 4(1): 39-50. PubMed | Google Scholar


27. Mok CC, Yap DY, Navarra SV et al. Overview of lupus nephritis management guidelines and perspective from Asia. Nephrology. 2014; 19(1): 11-20. PubMed | Google Scholar


28. Weinstein A, Bordwell B, Stone B et al. Antibodies to native DNA and serum complement (C3) levels, application to diagnosis and classification of systemic lupus erythematosus. Am J Med. 1983; 74(2): 206-216. PubMed | Google Scholar


29. Sanchez-Guerrero J, Lew RA, Fossel AH et al. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum. 1996; 39(6): 1055-1061. PubMed | Google Scholar


30. Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatol. 1992; 10(3): 255-261. PubMed | Google Scholar


31. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus. 1993; 2(1): 15-19. PubMed | Google Scholar


32. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM. Systemic lupus erythematosus in Greece, clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus. 1993; 2(5): 303-312. PubMed | Google Scholar


33. Cervera R, Viñas O, Ramos-Casals M et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis. 2003; 62(5):431-434. PubMed | Google Scholar


34. Adams LE, Mongey AB. Role of genetic factors in drug-related autoimmunity. Lupus. 1994; 3(6):443-447. PubMed | Google Scholar


35. Senécal JL, Rauch J, Grodzicky T et al. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999; 42(7): 1347-1353. PubMed | Google Scholar


36. Dieudé M, Senécal JL, Rauch J et al. Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: lack of evidence for a direct role of lamin B1 in apoptotic blebs. Arthritis Rheum. 2002; 46(10): 2695-2707. PubMed | Google Scholar


37. Hussain WM, Fatani MI, Bukhari S. Systemic Lupus Erythematosus in Makkah, Saudi Arabia. Kuwait Medical Journal. 2005; 37(4): 267-270. PubMed | Google Scholar


38. Al-Jarallah K, Al-Awadi A, Siddiqui H et al. Systemic lupus erythematosus in Kuwait-hospital based study. Lupus. 1998; 7(7): 434-438. PubMed | Google Scholar


39. Anderson JD, Wang GS, Johnson JC et al. Autoantibody profile testing by immunodiffusion (ID) and hemagglutination (HA): comparison with routine immunofluorescent antinuclear antibody (FANA) testing. Arthritis Rheum. 1991; 34(Suppl): 1-8. PubMed | Google Scholar


40. Weinstein A, Bordwell B, Stone B et al. Antibodies to native DNA and serum complement (C3) levels, application to diagnosis and classification of systemic lupus erythematosus. Am J Med. 1983; 74(2): 206-216. PubMed | Google Scholar